PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-2.92%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-2.87%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-1.68%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-1.68%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-2.71%
Negative net income growth while QCOM stands at 41.85%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-3.18%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.45%
Reduced diluted shares while QCOM is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
25.02%
Maintaining or increasing dividends while QCOM cut them. John Neff might see a strong edge in shareholder returns.
-7.05%
Negative OCF growth while QCOM is at 5.57%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-9.93%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
66.42%
10Y revenue/share CAGR under 50% of QCOM's 174.44%. Michael Burry would suspect a lasting competitive disadvantage.
96.86%
5Y revenue/share CAGR at 50-75% of QCOM's 146.24%. Martin Whitman would worry about a lagging mid-term growth trajectory.
41.72%
3Y revenue/share CAGR under 50% of QCOM's 102.01%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
241.13%
10Y OCF/share CAGR under 50% of QCOM's 863.56%. Michael Burry would worry about a persistent underperformance in cash creation.
127.23%
5Y OCF/share CAGR is similar to QCOM's 116.65%. Walter Schloss might see parallel cost profiles or expansions producing comparable cash flow.
37.02%
3Y OCF/share CAGR 1.25-1.5x QCOM's 31.43%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
401.02%
Below 50% of QCOM's 2590.19%. Michael Burry would worry about a sizable gap in long-term profitability gains vs. the competitor.
252.29%
5Y net income/share CAGR at 50-75% of QCOM's 455.15%. Martin Whitman might see a shortfall in operational efficiency or brand power.
93.61%
3Y net income/share CAGR 50-75% of QCOM's 182.03%. Martin Whitman might see a lagging edge in short-term profitability vs. the competitor.
91.65%
Below 50% of QCOM's 1006.64%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
10.40%
Below 50% of QCOM's 174.05%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
-4.05%
Negative 3Y equity/share growth while QCOM is at 60.37%. Joel Greenblatt demands an urgent fix in capital structure or profitability vs. the competitor.
361.20%
Dividend/share CAGR of 361.20% while QCOM is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
355.42%
Dividend/share CAGR of 355.42% while QCOM is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
294.10%
3Y dividend/share CAGR above 1.5x QCOM's 96.94%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
-13.89%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-2.21%
Inventory is declining while QCOM stands at 18.43%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-7.70%
Negative asset growth while QCOM invests at 0.27%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-7.50%
We have a declining book value while QCOM shows 0.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
-6.09%
Our R&D shrinks while QCOM invests at 5.95%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.63%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.